Literature DB >> 17127485

Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study.

Florian Setzer1, Volker Oberle, Markus Bläss, Eva Möller, Stefan Russwurm, Hans-Peter Deigner, Ralf A Claus, Michael Bauer, Konrad Reinhart, Wolfgang Lösche.   

Abstract

Platelet-derived microvesicles (PMV) that are shed from the plasma membrane of activated platelets, expose various platelet-type antigens on their surface and are able to adhere to other blood cells and endothelial cells. There are several clinical conditions with markedly increased numbers of PMV, e.g. acute coronary syndrome, thrombotic microangiopathy and sepsis. To prove whether PMV may contribute to an inflammatory response we used DNA microarray technology to study the effect of PMV on gene expression in the prototypic monocytic cell line MonoMac 6 (MM6). PMV were generated by activating human platelets in plasma with collagen and subsequent removal of platelets and plasma by repeated centrifugation. MM6 were incubated for 2 h with PMV in a ratio corresponding to 75 platelets/cell, or saline as control. After RNA isolation, reverse transcription and fluorescence labelling, cDNA was hybridized on a medium density microarray comprising 5308 probes addressing 4868 transcripts of 4730 human genes relevant to inflammation, immune response and related processes. The formation of PMV-MM6 conjugates was associated with significant variations in gene expression, i.e. 93 genes were found to be differentially expressed (P < 0.001; q < 0.087). Among them, 47 genes with annotated transcripts and proteins were identified. Using Ingenuity Pathway Analysis, 37 of the differentially expressed genes were identified as parts of networks associated with functional pathways including cell-to-cell signalling, cellular growth and proliferation, regulation of gene expression and lipid metabolism. For sphingosine kinase-1 the increased expression could be confirmed exemplarily not only by RT-PCR but also on the enzyme activity level. The data indicate that PMV signal differential expression of inflammation-relevant genes in monocytic cells and may represent a novel link between hemostasis and inflammation.

Entities:  

Mesh:

Year:  2006        PMID: 17127485     DOI: 10.1080/09537100600760244

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  12 in total

1.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases.

Authors:  Günter Müller
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-07       Impact factor: 3.168

2.  Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes.

Authors:  Bernardo Lombo; José G Díez
Journal:  Core Evid       Date:  2011-03-17

3.  Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?

Authors:  Wolfgang Lösche; Janina Boettel; Björn Kabisch; Johannes Winning; Ralf A Claus; Michael Bauer
Journal:  Thrombosis       Date:  2011-11-09

4.  MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3.

Authors:  Hongwei Liang; Xin Yan; Yi Pan; Yongsheng Wang; Nan Wang; Limin Li; Yuan Liu; Xi Chen; Chen-Yu Zhang; Hongwei Gu; Ke Zen
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

5.  Analysis of serum miRNA profiles of myasthenia gravis patients.

Authors:  Gisela Nogales-Gadea; Alba Ramos-Fransi; Xavier Suárez-Calvet; Miquel Navas; Ricard Rojas-García; Jose Luis Mosquera; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Isabel Illa
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

Review 6.  Platelets and their chemokines in atherosclerosis-clinical applications.

Authors:  Philipp von Hundelshausen; Martin M N Schmitt
Journal:  Front Physiol       Date:  2014-08-08       Impact factor: 4.566

Review 7.  Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.

Authors:  Lina Badimon; Rosa Suades; Eduardo Fuentes; Iván Palomo; Teresa Padró
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

8.  Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study.

Authors:  Shmeylan A Al Harbi; Hani M Tamim; Hasan M Al-Dorzi; Musharaf Sadat; Yaseen M Arabi
Journal:  BMC Pharmacol Toxicol       Date:  2016-02-05       Impact factor: 2.483

9.  Detection of microRNA expression in human peripheral blood microvesicles.

Authors:  Melissa Piper Hunter; Noura Ismail; Xiaoli Zhang; Baltazar D Aguda; Eun Joo Lee; Lianbo Yu; Tao Xiao; Jeffrey Schafer; Mei-Ling Ting Lee; Thomas D Schmittgen; S Patrick Nana-Sinkam; David Jarjoura; Clay B Marsh
Journal:  PLoS One       Date:  2008-11-11       Impact factor: 3.240

10.  Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach.

Authors:  Daniel Rittirsch; Veit Schoenborn; Sandro Lindig; Elisabeth Wanner; Kai Sprengel; Sebastian Günkel; Barbara Schaarschmidt; Sonja Märsmann; Hans-Peter Simmen; Paolo Cinelli; Michael Bauer; Ralf A Claus; Guido A Wanner
Journal:  Crit Care       Date:  2015-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.